Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial
- Ana C. Veneziani
- Stephanie Lheureux
- Douglas G. Millar
- Neesha Dhani
- Ilaria Colombo
- Ainhoa Madariaga
- Pamela Soberanis Pina
- Swati Atale
- Yin-Ling Chan
- Joshua Lee
- Janelle Ramsahai
- Judy Quintos
- Lisa Wang
- Xuan Li
- Valerie Bowering
- Pam Ohashi
- Ben Wang
- Amit M. Oza
2026-05-13